Shandra Eisenga Human Cell and Tissue Product Safety Act
Introduced
Moved
Reached a final decision
Introduced 2025-02-06
Derived from the official record below.
Officially: “Shandra Eisenga Human Cell and Tissue Product Safety Act” Read the full text
Health
What it does
Shandra Eisenga Human Cell and Tissue Product Safety Act This bill establishes civil penalties for violations of regulations governing the donation and handling of human cell and tissue products. It also requires the Food and Drug Administration (FDA) to report on the regulation of these products and to provide related information to stakeholders. ( Human cell and tissue products are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.) Specifically, the bill establishes civil penalties for violations of the FDA’s regulations on donor elig
Summary by the Congressional Research Service, from the official record. Plain-language AI rewrite coming. Not legal advice.
Where it is
Introduced · 2025-02-06
In the House.
Passed the House · 2025-06-23
Senate floor vote · next
Official documents
Full bill textread it on this site, version rfs (Referred in Senate), as published by GovInfo
officialCongressional Budget Office cost estimatewhat it would cost, by the nonpartisan CBO
officialThe on-site text is shown verbatim from the GovInfo publication, captured 2026-07-23. The same version at GovInfo.
The numbers
29%
of bills that passed one chamber became law in the 118th Congress, 2023 to 2024 (n=939)
2
sponsors, out of 218 needed to pass
Who is lobbying on this
UNIVERSITY OF MICHIGANvia UNIVERSITY OF MICHIGAN
5 filingsSUSAN B ANTHONY LISTvia SUSAN B ANTHONY LIST
2 filingsFrom 7 filings in federal lobbying disclosures (LDA), via lda.gov, naming this bill (2025 to 2026). Filings are self-reported by lobbying firms and show who is paid to influence this bill. They do not say which side, or whether it worked.
Every fact on this page links to its source, starting with the official bill record. Last action: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (2025-06-24).